John C. Byrd,Danilo Perrotti,Ching-Shih Chen,James T. Dalton,Frank Frissora,Xiaobin Zhao,Qing Liu,Natarajan Muthusamy
申请号：
US12302953
公开号：
US08318812B2
申请日:
2007.06.01
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Methods—for treatment and prevention of lymphoid malignancies, including, but not limited to acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), B-cell lymphoma, Acute Myeloid leukemia (AML), and mantle cell lymphoma (MCL). The methods include administration of a therapeutically effective amount of FTY720 (2-Amino-2-[2-(4-octylphenyl)ethyl]propane 1,3-diol hydrochloride) or a derivative, pharmaceutically acceptable salt thereof, or a prodrug thereof to a subject.
